查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1846204

金奈米粒子：市場佔有率分析、行業趨勢、統計數據和成長預測（2025-2030 年）

Gold Nanoparticles - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計 2025 年金奈米粒子市場規模將達到 60.1 億美元，預計到 2030 年將達到 105.4 億美元，預測期內（2025-2030 年）的複合年成長率為 11.89%。

金奈米粒子-市場-IMG1

精準醫療計畫的興起、電子產品的持續微型化以及連續流綠色合成技術的進步，共同推動了醫療保健、半導體、能源和環境等領域對高純度奈米顆粒的需求。標靶藥物輸送平台已佔目前銷售額的26.11%，並且隨著監管機構核准更多診療測試，其持續吸引投資。連續流和微流體合成生產線正在快速擴展，減少了批次差異和危險廢棄物，同時降低了生產商的營運成本。在需求方面，醫療保健產業正經歷最快的成長，而隨著軟性和印刷感測器從實驗室走向量產，電子產業正經歷最快的成長。雖然黃金價格波動仍然是一個商業風險，但降低單位貴金屬負載的塗層和回收計劃將在短期內緩解利潤率波動。

全球黃金奈米粒子市場趨勢與洞察

奈米技術在醫療產業的應用日益廣泛

醫院、受託研究機構和設備製造商正在從被動藥物載體轉向多功能治療診斷結構，將成像和治療結合在一個金核中，使臨床醫生能夠透過光熱加熱摧毀腫瘤，同時即時追蹤治療。 DNA條碼奈米粒子庫使腫瘤學家能夠在單一患者樣本中篩檢多種有效載荷組合，縮短臨床前測試時間並提高難治性惡性腫瘤的反應率。監管機構正在加快對表現出明確生物相容性的奈米藥物的審查途徑，幫助三個美國臨床計畫在2025年推進到第二階段。調查團隊也正在研究可以將相同的等離子體加熱原理應用於微創腦刺激的神經介面塗層。隨著資料集檢驗了長期安全性，醫院採購集團正在為與標準影像處理主機整合的奈米粒子引導消融系統累計。到2025年，這些轉變將使金奈米粒子市場總合年成長率增加3.2個百分點。

擴大在高階電子和光電領域的應用

智慧型手錶、電子紡織品和嵌入式感測器製造商正在將金奈米線插入超薄電路中，以提高導電性，同時將彎曲半徑限制在 1 毫米以內。光電研究表明，在有機太陽能電池的光吸收器中嵌入 10 奈米球體，可透過局部表面等離子體放大將能量轉換效率提高 30% 以上。 RFID 開發人員正在利用金種子來提高吉赫頻率下的天線增益，從而無需增加標籤尺寸即可擴大讀取範圍。可噴墨列印的奈米粒子油墨在低於 120°C 的溫度下燒結，使其與穿戴式裝置中使用的 PET 和 TPU 薄膜相容，從而有助於生產準備。日本、韓國和台灣的工廠已經開始商業出貨，為全球提供筆記型電腦、智慧型手機和物聯網模組。

黃金價格波動

2025 年上半年，由於投資人在地緣政治衝擊中尋求避風港，基準裸金屬價格上漲近 25%，導致奈米顆粒製造商的原物料成本升至多年高點。同期，交易所交易基金 (ETF) 增持超過 160 噸，從工業通路吸走了供應。雖然許多設備原始設備製造商每季度都會簽訂契約，但現貨價格上漲會在幾週內反映在特種油墨和試劑目錄中，從而減緩了診斷和印刷電子等利基領域的計劃推出。避險可以部分緩解壓力，但會增加營運資金需求，擠壓小型企業。保護塗層可以將每個晶片的金屬含量降低 30%，雖然可以緩解衝擊，但其應用主要局限於需要厚實、生物相容性外殼的醫療應用。這種限制將使短期複合年成長率降低 2.3 個百分點，直到裸金屬價格穩定或回收產量比率率提高。

細分分析

到2024年，化學還原法將佔金奈米顆粒市場規模的40.55%，這一地位源自於北美和歐洲成熟的批量生產基礎設施。然而，下游用戶如今要求更嚴格的粒徑分佈和更低的溶劑足跡，這使得採購決策傾向於連續管線。預計到2030年，連續流水線的複合年成長率將達到12.45%。工廠營運商正在改造渦流流體模組，將前體流剪切成微米級薄膜，促進均勻成核，同時將副產物氫氣就地捕獲用作鍋爐燃料。人工智慧引導的感測器即時調整停留時間環路，使多分散性指數低於0.08，並提高製藥客戶的批次間可重複性。

此外，連續流反應器採用水性介質和大氣壓力，與檸檬酸鹽間歇製程相比，能耗強度降低了近三分之一。同一滑軌上的堆疊式種子介導生長方案允許在不打開系統的情況下製造棒狀、棱柱狀和核殼結構，從而最大限度地降低了污染風險。高解析度生物感測器的開發商擴大採用由流量開關編程生成的客製化幾何形狀，從而獲得了比商品膠體更高的利潤率。分析師預計，隨著檢驗批次規模的擴大，到2028年，連續流產能佔有率將超過30%，鞏固其作為受監管治療和診斷終端用途新基準的地位。

區域分析

到2024年，北美將佔全球銷售額的36.33%，這得益於雄厚的研發預算、FDA對品質的監管以及連接學術實驗室和契約製造製造商的一體化供應鏈。波士頓和聖地牙哥的產學研聯盟正在支持新興企業的分拆，這些公司將獲得奈米顆粒智慧財產權的授權，用於腫瘤學、心臟病學和神經病學領域的應用。美國國立衛生研究院(NIH)將於2025年提供一項刺激計畫津貼，將進一步擴大美國試點產能，並縮短臨床級材料的前置作業時間。

亞太地區的複合年成長率為12.98%，是最快的，這得益於中國的大型膠體反應器、印度不斷擴張的學名藥行業以及日本的感測器創新生態系統。廣東省和浙江省推出了政策獎勵，為符合ISO 14001標準的連續流水線提供高達20%的資本支出返還，以加快其綠色生產足跡的步伐。首爾和新竹的半導體公司正在消耗大量奈米顆粒用於高密度中介層和熱感墊片，而東協的電子產品出口商則將印刷天線用於物流追蹤器和智慧包裝標籤。

歐洲正在平衡監管的嚴謹性與永續性的領導力，並透過「地平線歐洲」津貼支持市場發展，優先發展綠色化學升級和循環經濟試點計畫。一家德國汽車供應商正在檢驗一款專為下一代燃料電池汽車設計的金催化氮氧化物減排模組。同時，一個北歐醫療技術叢集正在將奈米顆粒標籤納入一種旨在即時診斷的快速初步試驗檢測中，以應對歐盟「戰勝癌症計劃」下的一項公共衛生優先事項。

其他福利：

  • Excel 格式的市場預測 (ME) 表
  • 3個月的分析師支持

目錄

第1章 引言

  • 研究假設和市場定義
  • 調查範圍

第2章調查方法

第3章執行摘要

第4章 市場狀況

  • 市場概況
  • 市場促進因素
    • 奈米技術在醫療產業的應用不斷擴大
    • 擴大在高階電子和光電領域的應用
    • 永續的綠色合成方法，降低監管風險
    • 精準腫瘤學對診療藥物的需求
    • 用於物聯網設備的下一代軟性/印刷感測器
  • 市場限制
    • 黃金價格波動
    • 安全性和長期毒性問題
    • 奈米材料替代品的出現（例如量子點）
  • 價值鏈分析
  • 五力分析
    • 供應商的議價能力
    • 消費者議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭程度

第5章市場規模及成長預測

  • 依合成方法
    • 化學還原
    • 綠色/生物合成
    • 種子型成長
    • 常規流動和微流體
    • 其他方法
  • 按用途
    • 影像學
    • 藥物輸送
    • 感應器
    • 體外診斷
    • 探測
    • 催化作用
    • 其他用途
  • 按最終用戶產業
    • 電子和半導體
    • 醫療保健和生命科學
    • 化學/催化
    • 能源與環境
    • 其他最終用戶產業
  • 按地區
    • 亞太地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • ASEAN
      • 其他亞太地區
    • 北美洲
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 義大利
      • 北歐
      • 俄羅斯
      • 其他歐洲國家
    • 南美洲
      • 巴西
      • 阿根廷
      • 南美洲其他地區
    • 中東和非洲
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 南非
      • 其他中東和非洲地區

第6章 競爭態勢

  • 市場集中度
  • 策略舉措
  • 市佔率（%）/排名分析
  • 公司簡介
    • Abcam
    • Aurion
    • BBI Solutions
    • Creative Diagnostics
    • Cytodiagnostics Inc.
    • Johnson Matthey Plc
    • Meliorum Technologies Inc.
    • Merck KGaA
    • nanoComposix
    • NanoHybrids
    • Nanopartz Inc.
    • Sona Nanotech Inc.
    • TANAKA Holdings Co., Ltd.

第7章 市場機會與未來展望

簡介目錄
Product Code: 64912

The Gold Nanoparticles Market size is estimated at USD 6.01 billion in 2025, and is expected to reach USD 10.54 billion by 2030, at a CAGR of 11.89% during the forecast period (2025-2030).

Gold Nanoparticles - Market - IMG1

Escalating precision-medicine programs, persistent electronics miniaturization, and progress in continuous-flow green synthesis collectively lift demand for high-purity nanoparticles across healthcare, semiconductor, energy, and environmental use cases. Targeted drug-delivery platforms already account for 26.11% of current revenue and continue to attract investment as regulators approve more theranostic trials. Continuous-flow and microfluidic synthesis lines are scaling rapidly, lowering batch variability and hazardous-waste volumes while cutting operating expenses for producers. On the demand side, healthcare commands the largest uptake, yet the electronics segment registers the highest growth velocity as flexible and printed sensors migrate from lab to mass production. Gold-price volatility remains an operational risk, but coatings that reduce precious-metal loading per unit and recycling initiatives buffer near-term margin swings.

Global Gold Nanoparticles Market Trends and Insights

Rising Nanotechnology Applications in Medical Industry

Hospitals, contract research organizations, and device makers are moving beyond passive drug carriers to multifunction theranostic constructs that combine imaging and therapy on a single gold core, enabling clinicians to destroy tumors via photothermal heating while concurrently tracking treatment in real time. DNA-barcoded nanoparticle libraries now let oncologists screen several payload combinations inside one patient sample, cutting preclinical timelines and raising response rates for hard-to-treat malignancies. Regulatory agencies have accelerated review pathways for nanomedicines that demonstrate clear biocompatibility, helping three US clinical programs move into Phase II during 2025. Research teams are also probing neural-interface coatings that could translate the same plasmonic heating principle to minimally invasive brain stimulation. As datasets validate long-term safety profiles, hospital purchasing groups are earmarking budget for nanoparticle-guided ablation systems that integrate with standard imaging consoles. These transitions collectively add 3.2 percentage points to the gold nanoparticles market CAGR through mid-decade.

Growing Adoption in High-End Electronics & Photonics

Smart-watch, e-textile, and implantable sensor makers insert gold nanowires into ultrathin circuitry to raise conductivity while keeping bending radii below 1 mm, a key threshold for comfortable skin-mounted patches. Photonics research shows that embedding 10 nm spheres inside organic solar-cell photo-absorbers can lift power-conversion efficiency by more than 30% through localized surface-plasmon amplification RFID developers leverage gold seeds to boost antenna gain at gigahertz frequencies, widening read ranges without increasing tag size. Production readiness is high thanks to inkjet-printable nanoparticle inks that sinter at temperatures below 120 °C, compatible with PET and TPU films used in wearables. The electronics driver injects 2.8 points into forecast CAGR, with commercial shipments already ramping at factories in Japan, South Korea, and Taiwan that supply the global notebook, smartphone, and IoT modules sectors.

Volatility in Gold Prices

Benchmark bullion prices climbed almost 25% during the first half of 2025 as investors sought havens amid geopolitical shocks, pushing nanoparticle producers' raw-material spend to multi-year highs. Exchange-traded funds added more than 160 tonnes during the same window, siphoning supply from industrial channels. Many device OEMs lock quarterly contracts, yet spot spikes feed through to specialty ink and reagent catalogs within weeks, delaying project launches in diagnostics and printed-electronics niches. Hedging offers partial relief but raises working-capital needs, squeezing small firms that lack scale. Protective coatings that enable 30% metal-content reduction per chip are mitigating the blow, though adoption is uneven in medical segments that demand thicker biocompatible shells. The restraint subtracts 2.3 points from near-term CAGR until bullion prices stabilize or recycling yields improve.

Other drivers and restraints analyzed in the detailed report include:

  1. Sustainable Green Synthesis Methods Lowering Regulatory Risk
  2. Precision Oncology Demand for Theranostic Agents
  3. Safety & Long-Term Toxicity Concerns

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Chemical reduction accounted for 40.55% of the gold nanoparticles market size in 2024, a legacy position rooted in established batch infrastructure across North America and Europe. Yet downstream users now demand tighter particle-size distributions and lower solvent footprints, tipping procurement decisions toward continuous-flow lines that log a robust 12.45% CAGR to 2030. Plant operators retrofit vortex-fluidic modules that shear precursor streams into micron-thick films, promoting uniform nucleation while capturing hydrogen coproduct for on-site boiler fuel. AI-guided sensors adjust residence-time loops in real time, holding polydispersity indexes below 0.08 and elevating lot-to-lot reproducibility for pharmaceutical customers.

The shift also intersects with green-chemistry imperatives because flow reactors use aqueous media and ambient pressure, slashing energy intensity by nearly one-third versus citrate batch routes. Seed-mediated growth schemes layered onto the same skid allow production of rods, prisms, and core-shell configurations without opening the system, minimizing contamination risk. Developers of high-resolution biosensors increasingly embed bespoke shapes generated via flow-switch programming, capturing margin premiums well above commodity colloids. As validation batches scale, analysts expect continuous-flow capacity share to pass 30% by 2028, cementing its status as the new reference standard for regulated therapeutic and diagnostic end uses.

The Gold Nanoparticles Market Report is Segmented by Synthesis Method (Chemical Reduction, Green/Biological Synthesis, and More), Application (Imaging, Targeted Drug Delivery, and More), End-User Industry (Electronics & Semiconductors, Healthcare & Life Sciences, and More), and Geography (Asia-Pacific, North America, Europe, South America, Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Geography Analysis

North America retained 36.33% of global revenue in 2024, underpinned by deep R&D budgets, FDA oversight that standardizes quality, and integrated supply chains bridging academic labs with contract manufacturers. Academic-industry consortia in Boston and San Diego help spin off start-ups that license nanoparticle IP for oncology, cardiology, and neurology applications. Stimulus grants channeled through the National Institutes of Health in 2025 further enlarge domestic pilot capacities, ensuring short lead times for clinical-grade material.

Asia-Pacific posts the swiftest 12.98% CAGR, reflecting China's large-scale colloid reactors, India's expanding generics sector, and Japan's sensor innovation ecosystem. Policy incentives in Guangdong and Zhejiang provinces reimburse up to 20% of capital outlays for continuous-flow lines that meet ISO 14001 benchmarks, fast-tracking green production footprints. Semiconductor companies headquartered in Seoul and Hsinchu consume rising nanoparticle volumes for high-density interposers and thermal-interface pads, while ASEAN electronics exporters use printed antennas in logistics trackers and smart-package labels.

Europe balances regulatory rigour with sustainability leadership, supporting market development through Horizon Europe grants that prioritize green-chemistry upgrades and circular-economy pilot trials. German automotive suppliers validate gold-catalyzed NOx-reduction modules engineered for next-generation fuel-cell vehicles. Meanwhile, Nordic med-tech clusters incorporate nanoparticle tags into rapid-sepsis tests aimed at point-of-care settings, addressing public-health priorities under the EU's Beating Cancer Plan.

  1. Abcam
  2. Aurion
  3. BBI Solutions
  4. Creative Diagnostics
  5. Cytodiagnostics Inc.
  6. Johnson Matthey Plc
  7. Meliorum Technologies Inc.
  8. Merck KGaA
  9. nanoComposix
  10. NanoHybrids
  11. Nanopartz Inc.
  12. Sona Nanotech Inc.
  13. TANAKA Holdings Co., Ltd.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Nanotechnology Applications in Medical Industry
    • 4.2.2 Growing Adoption in High-end Electronics and Photonics
    • 4.2.3 Sustainable Green Synthesis Methods Lowering Regulatory Risk
    • 4.2.4 Precision Oncology Demand for Theranostic Agents
    • 4.2.5 Next-Gen Flexible/Printed Sensors for IoT Devices
  • 4.3 Market Restraints
    • 4.3.1 Volatility in Gold Prices
    • 4.3.2 Safety and Long-term Toxicity Concerns
    • 4.3.3 Emerging Nano-material Substitutes (e.g., Quantum Dots)
  • 4.4 Value Chain Analysis
  • 4.5 Porter's Five Forces
    • 4.5.1 Bargaining Power of Suppliers
    • 4.5.2 Bargaining Power of Consumers
    • 4.5.3 Threat of New Entrants
    • 4.5.4 Threat of Substitute Products and Services
    • 4.5.5 Degree of Competition

5 Market Size and Growth Forecasts (Value)

  • 5.1 By Synthesis Method
    • 5.1.1 Chemical Reduction
    • 5.1.2 Green/Biological Synthesis
    • 5.1.3 Seed-mediated Growth
    • 5.1.4 Continuous Flow and Microfluidic
    • 5.1.5 Other Methods
  • 5.2 By Application
    • 5.2.1 Imaging
    • 5.2.2 Targeted Drug Delivery
    • 5.2.3 Sensors
    • 5.2.4 In Vitro Diagnostics
    • 5.2.5 Probes
    • 5.2.6 Catalysis
    • 5.2.7 Other Applications
  • 5.3 By End-user Industry
    • 5.3.1 Electronics and Semiconductors
    • 5.3.2 Healthcare and Life Sciences
    • 5.3.3 Chemicals and Catalysts
    • 5.3.4 Energy and Environmental
    • 5.3.5 Other End-User Industries
  • 5.4 By Geography
    • 5.4.1 Asia-Pacific
      • 5.4.1.1 China
      • 5.4.1.2 India
      • 5.4.1.3 Japan
      • 5.4.1.4 South Korea
      • 5.4.1.5 ASEAN
      • 5.4.1.6 Rest of Asia-Pacific
    • 5.4.2 North America
      • 5.4.2.1 United States
      • 5.4.2.2 Canada
      • 5.4.2.3 Mexico
    • 5.4.3 Europe
      • 5.4.3.1 Germany
      • 5.4.3.2 United Kingdom
      • 5.4.3.3 France
      • 5.4.3.4 Italy
      • 5.4.3.5 NORDIAC
      • 5.4.3.6 Russia
      • 5.4.3.7 Rest of Europe
    • 5.4.4 South America
      • 5.4.4.1 Brazil
      • 5.4.4.2 Argentina
      • 5.4.4.3 Rest of South America
    • 5.4.5 Middle East and Africa
      • 5.4.5.1 Saudi Arabia
      • 5.4.5.2 United Arab Emirates
      • 5.4.5.3 South Africa
      • 5.4.5.4 Rest of Middle East and Africa

6 Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Strategic Moves
  • 6.3 Market Share(%)/ Ranking Analysis
  • 6.4 Company Profiles (includes Global Overview, Market Overview, Core Segments, Financials, Strategic Information, Market Rank/Share, Products and Services, Recent Developments)
    • 6.4.1 Abcam
    • 6.4.2 Aurion
    • 6.4.3 BBI Solutions
    • 6.4.4 Creative Diagnostics
    • 6.4.5 Cytodiagnostics Inc.
    • 6.4.6 Johnson Matthey Plc
    • 6.4.7 Meliorum Technologies Inc.
    • 6.4.8 Merck KGaA
    • 6.4.9 nanoComposix
    • 6.4.10 NanoHybrids
    • 6.4.11 Nanopartz Inc.
    • 6.4.12 Sona Nanotech Inc.
    • 6.4.13 TANAKA Holdings Co., Ltd.

7 Market Opportunities and Future Outlook

  • 7.1 White-space and Unmet-Need Assessment
  • 7.2 Innovation in the Field of Electronics